Prot #JK07.2.01: A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of JK07 in Adults With Chronic Heart Failure (RENEU-HF)

Project: Research project

Project Details

StatusActive
Effective start/end date11/19/24 → 11/19/27

Funding

  • Medpace Clinical Research LLC (Prot #JK07.2.01 // Prot #JK07.2.01)
  • Salubris Biotherapeutics, Inc. (Prot #JK07.2.01 // Prot #JK07.2.01)